Journal of Neuroscience Nursing

Editor-in-Chief: DaiWai M. Olson, PhD RN CCRN FNCS
ISSN: 0888-0395
Online ISSN: 1945-2810
Frequency: 6 issues per year
Impact Factor: .815
National Nurses Week 2016


In honor of Nurses Week, enjoy the current issue of Journal of Neuroscience Nursing for free!

Plus, we will continue celebrating nurses all month long, because a week is just not enough.

To say thanks for all that you do, we are offering additional free content, special discount offers and more, in conjunction with our partners at Wolters Kluwer and

Be sure to join the conversation on Social Media by using the hashtags below:




Current Issue Highlights


 ‭(Hidden)‬ SubscriptionErrorMessageWebPart

American Association of Neuroscience Nurses Official Journal of
American Association of Neuroscience Nurses

To receive access to the online journal, association members must log-in through the AANN website in the members-only area. Please click below:

American Association of Neuroscience Nurses

In the News
News you can use .... Migraine headaches are featured in the 12/13th New York Times -- an opinion piece by Michele Williams allows the reader to "live" her experiences with migraines, their diagnosis and misdiagnosis, treatment approaches, and the effects on daily life. This issue also examines migraines in professional football players. Despite the ever-present focus on concussions and their effects in players, something as seemingly mundane as recurrent headaches often plays havoc with their ability to function during a game. It's hard to imagine experiencing a full-blown migraine with nausea, photophobia and pain while tackling or being tackled and hearing the roar of 70,000+ fans. The FDA recently released their advice related to the potential risks inherent in epidural glucocorticoid injections. This off-label practice has come to the fore after patients developed serious and sometimes fatal neurologic events post-injection. After a lengthy review, no changes in the current FDA warnings will be made but the panel recommends careful patient selection and honest evaluations of risk v. benefit. They point out that the evidence supporting efficacy of this treatment is inconclusive.